ValuEngine Upgrades Select Medical (SEM) to Hold

ValuEngine upgraded shares of Select Medical (NYSE:SEM) from a sell rating to a hold rating in a research note published on Wednesday morning, ValuEngine reports.

Other equities analysts have also issued research reports about the stock. TheStreet lowered shares of Select Medical from a b- rating to a c+ rating in a research report on Tuesday, March 26th. Zacks Investment Research raised shares of Select Medical from a strong sell rating to a hold rating in a research report on Tuesday, March 12th. Barclays reaffirmed a hold rating and set a $16.00 price target on shares of Select Medical in a research report on Thursday, May 9th. Finally, JMP Securities raised shares of Select Medical from a market perform rating to an outperform rating and set a $18.00 price target for the company in a research report on Friday, May 17th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $16.67.

NYSE:SEM opened at $14.67 on Wednesday. Select Medical has a 1-year low of $12.96 and a 1-year high of $21.65. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 4.46. The company has a market capitalization of $1.99 billion, a PE ratio of 14.24, a PEG ratio of 1.01 and a beta of 1.30.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $0.27 EPS for the quarter, hitting the consensus estimate of $0.27. Select Medical had a net margin of 2.80% and a return on equity of 14.26%. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the business posted $0.29 earnings per share. Select Medical’s revenue for the quarter was up 5.7% compared to the same quarter last year. Research analysts anticipate that Select Medical will post 1.08 earnings per share for the current fiscal year.

In related news, Vice Chairman Rocco A. Ortenzio purchased 41,948 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $14.24 per share, with a total value of $597,339.52. Following the completion of the transaction, the insider now owns 1,047,143 shares of the company’s stock, valued at approximately $14,911,316.32. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Rocco A. Ortenzio acquired 306,189 shares of the firm’s stock in a transaction on Monday, March 18th. The shares were acquired at an average price of $14.18 per share, with a total value of $4,341,760.02. Following the completion of the purchase, the insider now owns 1,047,143 shares of the company’s stock, valued at $14,848,487.74. The disclosure for this purchase can be found here. Corporate insiders own 19.50% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SEM. Resources Investment Advisors Inc. purchased a new stake in Select Medical during the fourth quarter worth approximately $28,000. Parallel Advisors LLC grew its stake in Select Medical by 2,889.2% during the first quarter. Parallel Advisors LLC now owns 2,481 shares of the health services provider’s stock worth $35,000 after buying an additional 2,398 shares during the period. Quantamental Technologies LLC purchased a new stake in Select Medical during the fourth quarter worth approximately $36,000. Oregon Public Employees Retirement Fund purchased a new stake in Select Medical during the fourth quarter worth approximately $41,000. Finally, PNC Financial Services Group Inc. grew its stake in Select Medical by 20.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,027 shares of the health services provider’s stock worth $93,000 after buying an additional 1,017 shares during the period. Institutional investors own 76.78% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More: Do investors pay a separate front-end load every time they buy additional shares?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.